1.24% +0.5435

SpringWorks Therapeutics Inc (SWTX)

SpringWorks Therapeutics Inc 주식(SWTX)의 최신 뉴스

SpringWorks Therapeutics Inc (SWTX)

SpringWorks Therapeutics Inc 주식(SWTX)의 최신 뉴스

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives $68.83 Average Price Target from Analysts - MarketBeat

Wall Street analysts' outlook for SpringWorks Therapeutics Inc (SWTX) – Sete News - SETE News

Stock Surge: SpringWorks Therapeutics Inc (SWTX) Closes at 41.43, Marking a 1.32 Increase/Decrease – DWinneX - The Dwinnex

Are SpringWorks Therapeutics Inc'shares a good deal? – US Post News - US Post News

Trend Tracker for (SWTX) - Stock Traders Daily

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Stock Holdings Lifted by Victory Capital Management Inc. - MarketBeat

Victory Capital Management Inc. Buys 328127 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World

Cwm LLC Sells 328 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World

SpringWorks Therapeutics (SWTX) Stock Forecast and Price Target 2024 - MarketBeat

Need To Know: Analysts Are Much More Bullish On SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Revenues - Simply Wall St

Russell Investments Group Ltd. Has $4.17 Million Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World

Equities Analysts Offer Predictions for SpringWorks Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:SWTX) - MarketBeat

SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference - Yahoo Finance

What was SpringWorks Therapeutics Inc (SWTX)'s performance in the last session? – US Post News - US Post News

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Q1 2024 Earnings Call Transcript - Insider Monkey

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Q1 2024 Earnings Call Transcript - Insider Monkey

Zurcher Kantonalbank Zurich Cantonalbank Purchases 2387 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World

We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth - Simply Wall St

Here's Why We're Not Too Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation - Yahoo Finance

SpringWorks Therapeutics (SWTX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates - GlobeNewswire

SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates

SpringWorks Therapeutics: Q1 Earnings Snapshot - Middletown Press

SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical ... - GlobeNewswire

SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Mutual of America Capital Management LLC Acquires New Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World

SpringWorks Therapeutics: Multiple Opportunities, But No Sure-Fire Winners (SWTX) - Seeking Alpha

SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024

SpringWorks Therapeutics Inc's results are impressive – US Post News - US Post News

SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the ... - GlobeNewswire

SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors

SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application ... - Yahoo Finance

SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates

SpringWorks Therapeutics: Q4 Earnings Snapshot - Quartz

SpringWorks Therapeutics to Present at Upcoming Investor Conferences

SpringWorks Therapeutics to Present at Upcoming Investor Conferences - Yahoo Finance

SpringWorks Therapeutics stock jumps amid takeover speculation - Seeking Alpha

Immunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Up

ROR1s, roar twice: ADC pro Siegall takes on tricky target at Immunome - BioWorld Online

SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

SpringWorks (SWTX) Surges More Than 80% in 3 Months: Here's Why

SpringWorks (SWTX) Surges More Than 80% in 3 Months: Here's Why - Yahoo Finance

SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference

SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual ... - Yahoo Finance

SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Osgiveo Earns FDA Approval to Treat Desmoid Tumors - Verywell Health

SpringWorks Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

SpringWorks Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of ... - Yahoo Finance

SpringWorks Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

SWTX과 유사한 종목